SOURCE: Universal Detection Technology

February 08, 2007 07:28 ET

Universal Detection Technology to Develop Smart Ticket Technology to Train First Responders

LOS ANGELES, CA -- (MARKET WIRE) -- February 8, 2007 -- Universal Detection Technology ( (OTCBB: UDTT), a developer of early-warning monitoring technologies to protect people from bioterrorism and provider of counter-terrorism training and solutions, announced today that the Company has commenced the development of technology that will train first responders in methods of using smart tickets without potential exposure to lethal pathogens such as the Anthrax spore.

UDT recently announced the sale of Anthrax Test Kits to the U.S. Army Dugway Proving Ground, the primary chemical and biological defense testing center for the military. Tests at Dugway determine the reliability and survivability of all types of military equipment in a chemical or biological environment. First Responders from all over travel to the Dugway Proving Ground to train on the latest procedures on dealing with biochemical threats.

Anthrax spores are highly infectious and cannot be used for training purposes. However, UDT's technology, based on an antigen-antibody reaction, uses a non-toxic, non-infectious protein powder that acts as a stimulant for Anthrax, thus giving First Responders first-hand experience on using the Kits.

"The development of the Kits will significantly enhance the readiness of First Responders in dealing with White Powder threats," said Amir Ettehadieh, Director of Research and Development at Universal Detection Technology. "The responders would have performed hundreds of tests with the benign powder before ever having to do the tests in a real-time scenario."

About Universal Detection Technology

Universal Detection Technology is a developer of monitoring technologies, including bioterrorism detection devices. The Company on its own and with development partners is positioned to capitalize on opportunities related to Homeland Security. For example, the Company, in cooperation with NASA, has developed a bioterror 'smoke' detector that detects certain biohazard substances. For more information, please visit

Forward-Looking Statements

Except for historical information contained herein, the statements in this news release are forward-looking statements that involve known and unknown risks and uncertainties, which may cause the Company's actual results, performance and achievement in the future to differ materially from forecasted results, performance, and achievement. The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events or changes in the Company's plans or expectations.

Contact Information

  • Contact:
    Jacques Tizabi